Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method

被引：0

作者：

Rabodoarivelo, Marie Sylvianne ^{[1
]}

Gomez, Ana Belen ^{[1
]}

Marco, Ana Pico ^{[1
]}

Martin, Carlos ^{[1
,2
,3
]}

Ramon-Garcia, Santiago ^{[1
,2
,4
]}

机构：

[1] Univ Zaragoza, Fac Med, Dept Microbiol Pediat Radiol & Salud Publ, Zaragoza, Spain

[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain

[3] Hosp Univ Miguel Servet, Serv Microbiol, ISS Aragon, Zaragoza, Spain

[4] Fdn Agencia Aragonesa Invest & Desarrollo Fdn ARAI, Zaragoza, Spain

来源：

关键词：

BCG vaccine; Drug susceptibility; EUCAST; MTBVAC; Mycobacterium tuberculosis;

D O I：

10.1016/j.cmi.2024.04.017

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1080 / 1082

页数：3